EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BDH1 promotes lung cancer cell proliferation and metastases by PARP1‐mediated autophagy

Zhimin Zhang iD, Xin Bi, Xiaojuan Lian, Zhongxi Niu

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Zhimin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery, The Third Medical Center of PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Lung Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph node metastases and distant metastases were the important limiting factor for therapy of unresectable locally advanced (IIIB stage) and oligotransduction (IVa stage) lung cancer. This study was undertaken to identify a novel predictive biomarker for predicting lymph node metastases of lung cancer. A total of 364 patients with lung cancer which comprised of 198 patients with transcriptome sequencing data, 110 cases with immunohistochemistry data and 66 patients with serum samples were included to identify and validate the candidate gene. Autophagy was measured by western blots, immunofluorescence and electron microscope. We found that 3‐hydroxybutyrate dehydrogenase 1 (BDH1) was associated with proliferation and metastases of lung cancer. BDH1 expression in both tissue and serum samples was associated with lung cancer metastases. Mechanical studies revealed that the AMPK‐mTOR signalling pathway mediated by PARP1 played an important role in BDH1‐induced autophagy. Activation of mTOR pathway markedly increased the effect of BDH1 in cell proliferation and metastases. These results were verified by the knockdown of PARP1. Furthermore, in vivo administration of BDH1 effectively promoted tumour growth in H460 xenografts mice. Our finding not only suggested that BDH1 might be useful as a novel biomarker and therapeutic target for lung cancer metastases, but also imply that PARP1‐mediated AMPK‐mTOR signalling pathway might play a critical role in BDH1‐induced autophagy and lung cancer proliferation and metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesLung NeoplasmsHumansMiceAnimalsLymphatic MetastasisTOR Serine-Threonine KinasesAutophagyCell ProliferationCell Line, TumorPoly (ADP-Ribose) Polymerase-1

Stichwörter der Autor:innen

lung cancermetastasespredictive markerserum BDH1therapeutic target

Substanzen

AMP-Activated Protein KinasesTOR Serine-Threonine KinasesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1

Autor:innen und Institutionen

  • Thoracic Surgery, The Third Medical Center of PLA General Hospital, Beijing, China.
  • Department of Tumor Blood, Chongqing University Jiangjin Hospital, Chongqing, China.

ORCID-Profile: Zhimin Zhang

Zitieren

APA

Zhang, Z., Bi, X., Lian, X., & Niu, Z. (2023). BDH1 promotes lung cancer cell proliferation and metastases by PARP1‐mediated autophagy. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17700

Vancouver

Zhang Z, Bi X, Lian X, Niu Z. BDH1 promotes lung cancer cell proliferation and metastases by PARP1‐mediated autophagy. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17700

BibTeX
@article{Zhang2023,
  author = {Zhang, Zhimin and Bi, Xin and Lian, Xiaojuan and Niu, Zhongxi},
  title = {BDH1 promotes lung cancer cell proliferation and metastases by PARP1‐mediated autophagy},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17700}
}
Kostenlos starten →